The Zoom call that followed was pivotal for the family. The professor explained that he believed Dr Wright was the first person to have suffered a rare reaction to the AstraZeneca Covid vaccine.
AstraZeneca says a strong 2024 and stacked pipeline spells potential for further growth in 2025 as the company aims to bring in $80bn in revenue by 2030. CFO Aradhana Sarin outlined AstraZeneca ...
AstraZeneca CFO Aradhana Sarin promised Phase III readouts and revenue growth in 2025 despite ongoing investigations of its Chinese operations. Credit: Bloomberg/ Getty Images AstraZeneca says a ...
Genome engineering business Synthego will have access to AstraZeneca’s CRISPR gene editing enzyme in its second licensing agreement in the past year.
Microsoft has recently introduced a new collection of desktop wallpapers to its website, offering a wide variety of wallpapers for download. The latest collection, ‘Fluid Textures,’ was designed by 3D ...
It’s now official: Johnson & Johnson’s combination of Rybrevant and Lazcluze has racked up an overall survival (OS) victory against AstraZeneca’s standard-of-care Tagrisso as a first-line ...
AstraZeneca AZN stock has declined 14% in the past three months. A lot of this price decline is due to ongoing investigations at its China subsidiary. However, the overall drug and biotech sector ...
AstraZeneca still trades at a premium valuation, but several factors limit its upside potential in the next visible period. There are three negative takeaways from China. IRA could also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback